How should an oncologist respond to a patient’s fear of death?
By Mikkael Sekeres, MD, MS
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Three-quarters of the way through inpatient rounds, my team and I stopped to see our patient, a woman in her 50s who had been given a diagnosis of acute lymphocytic leukemia and had been started on chemotherapy over three weeks earlier. She had been doing well and her blood counts were starting to recover, so she would soon go home.
Her eyes were anxious, though, and she wrung her hands.
I met her eyes, and smiled a bit. “You’ve done great throughout your chemotherapy course, you’re on minimal medications, and your bone marrow is recovering. We aren’t at all nervous about you,” I said. “Why are you worried?”
She exhaled, though I couldn’t tell if she did so because she was relieved to hear about her good health, or frustrated that she had to repeat herself. “I’ve seen family members die in the hospital and I don’t want that to happen to me,” she said. “Promise me I won’t die here.”
Read the full New York Times column by Dr. Sekeres, Director of Cleveland Clinic Cancer Center’s Leukemia Program.
Advertisement
Advertisement
Timing and type of side effects differ greatly from chemotherapy
Dedicated multidisciplinary teams support 84 ultra-rare cancers
Sessions explore treatment advances and multidisciplinary care
New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Early communication between oncologists and ophthalmologist warranted
Case-based course delves into latest treatment approaches
Long-term relationship building and engagement key to gaining community trust